These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21894473)

  • 1. Reduced intensity conditioning allogeneic hematopoietic stem cell transplant could be beneficial to angioimmunoblastic T-cell lymphoma patients with hemophagocytic lymphohistiocytosis.
    Yu JT; Hwang WL; Wang RC; Teng CL
    Ann Hematol; 2012 May; 91(5):805-807. PubMed ID: 21894473
    [No Abstract]   [Full Text] [Related]  

  • 2. False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphoma.
    Ulaner GA; Lilienstein J; Gönen M; Maragulia J; Moskowitz CH; Zelenetz AD
    J Clin Oncol; 2014 Jan; 32(1):51-6. PubMed ID: 24248697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine A and reduced-intensity conditioning allogeneic stem cell transplantation for relapsed angioimmunoblastic T cell lymphoma with hemophagocytic syndrome.
    Matsumura Y; Kuroda J; Shimura Y; Kiyota M; Yamamoto-Sugitani M; Kobayashi T; Matsumoto Y; Horiike S; Taniwaki M
    Intern Med; 2012; 51(19):2785-7. PubMed ID: 23037475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase inhibitor abexinostat (S78454/PCI-24781) as a successful approach in a case of refractory peripheral angio-immunoblastic T-cell lymphoma, as a bridge to reduced intensity conditioning haplo-identical allogenic stem cell transplant.
    Saillard C; El Cheikh J; Granata A; Coso D; Schiano JM; Bouabdallah R; Blaise D; Charrier N; Broussais F
    Leuk Lymphoma; 2016; 57(3):714-6. PubMed ID: 26750740
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk for complications in patients with hemophagocytic lymphohistiocytosis who undergo hematopoietic stem cell transplantation: myeloablative versus reduced-intensity conditioning regimens.
    Schechter T; Naqvi A; Weitzman S
    Expert Rev Clin Immunol; 2014 Aug; 10(8):1101-6. PubMed ID: 24871821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect.
    Dodero A; Spina F; Narni F; Patriarca F; Cavattoni I; Benedetti F; Ciceri F; Baronciani D; Scimè R; Pogliani E; Rambaldi A; Bonifazi F; Dalto S; Bruno B; Corradini P
    Leukemia; 2012 Mar; 26(3):520-6. PubMed ID: 21904377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolution of left and right ventricular thrombosis secondary to hypereosinophilic syndrome (lymphoproliferative variant) with reduced intensity conditioning allogenic stem cell transplantation.
    Bergua JM; Prieto-Pliego E; Román-Barberá A; García-Torón J; Gómez-Barrado JJ; Marcos G; López-Gómez L; Tomás JF
    Ann Hematol; 2008 Nov; 87(11):937-8. PubMed ID: 18521601
    [No Abstract]   [Full Text] [Related]  

  • 8. Controversies in autologous and allogeneic hematopoietic cell transplantation in peripheral T/NK-cell lymphomas.
    Shustov A
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):89-99. PubMed ID: 23768643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Case of Refractory Langerhans Cell Histiocytosis Complicated with Hemophagocytic Lymphohistiocytosis Rescued by Cord Blood Transplantation with Reduced-intensity Conditioning.
    Washio K; Muraoka M; Kanamitsu K; Oda M; Shimada A
    Acta Med Okayama; 2017 Jun; 71(3):249-254. PubMed ID: 28655945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemophagocytic lymphohistiocytosis with leukoencephalopathy in a patient with dermatomyositis accompanied with peripheral T-cell lymphoma: a case report.
    Teshigawara S; Katada Y; Maeda Y; Yoshimura M; Kudo-Tanaka E; Tsuji S; Harada Y; Matsushita M; Ohshima S; Watanabe K; Kumode T; Hoshida Y; Saeki Y
    J Med Case Rep; 2016 Aug; 10():212. PubMed ID: 27484255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
    Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
    Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan.
    Ohga S; Kudo K; Ishii E; Honjo S; Morimoto A; Osugi Y; Sawada A; Inoue M; Tabuchi K; Suzuki N; Ishida Y; Imashuku S; Kato S; Hara T
    Pediatr Blood Cancer; 2010 Feb; 54(2):299-306. PubMed ID: 19827139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory features and the successful transplantation of allogeneic peripheral blood stem cells in patients with lymphoma-associated hemophagocytic lymphohistiocytosis.
    Xudong L; Yi H; Dongning W; Yuan H; Wenwen W; Renwei H
    Clin Lab; 2014; 60(10):1765-8. PubMed ID: 25651724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Hematopoietic Stem Cell Transplantation in Treatment of Hemophagocytic Lymphohistiocytosis.
    Nikiforow S
    Hematol Oncol Clin North Am; 2015 Oct; 29(5):943-59. PubMed ID: 26461153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Umbilical cord blood transplantation induces a durable remission in hepatosplenic gamma-delta T cell lymphoma with associated hemophagocytic lymphohistiocytosis.
    Ayala E; Chalhoub J; Kharfan-Dabaja MA
    Am J Hematol; 2014 Sep; 89(9):934-5. PubMed ID: 24861697
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful stem cell transplant with antibody-based conditioning for XIAP deficiency with refractory hemophagocytic lymphohistiocytosis.
    Worth AJ; Nikolajeva O; Chiesa R; Rao K; Veys P; Amrolia PJ
    Blood; 2013 Jun; 121(24):4966-8. PubMed ID: 23766462
    [No Abstract]   [Full Text] [Related]  

  • 17. High-dose therapy and stem cell transplantation.
    Zinzani PL
    Semin Hematol; 2010 Apr; 47 Suppl 1():S15-7. PubMed ID: 20359581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EBV-positive peripheral T-cell lymphoma with extensive hemophagocytosis.
    Shah MV; Go RS
    Blood; 2014 Nov; 124(22):3329. PubMed ID: 25562103
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemophagocytosis and relapsed peripheral T-cell lymphoma.
    Gallipoli P; Drummond M; Leach M
    Eur J Haematol; 2009 Mar; 82(3):246. PubMed ID: 19018857
    [No Abstract]   [Full Text] [Related]  

  • 20. Graft-versus-lymphoma effect plus vorinostat as successful approach in a case of refractory gastric peripheral T cell lymphoma, not otherwise specified, after reduced intensity conditioning allogeneic hematopoietic cell transplant.
    Devarakonda SS; Shahan JL; Takalkar A; Chaudhery SI; Jean G; Koshy NV; Hildebrandt GC
    Leuk Lymphoma; 2013 Nov; 54(11):2545-7. PubMed ID: 23442066
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.